More tools:Markets·Screener·Research·Chat

Neuraxis, Inc. (NRXS) Financial Statements

Neuraxis, Inc.
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG01C9N1368
XASE · usd
5.88▼ 0.04 (-0.59%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close5.91
Day's Range5.81 – 6.04
52-Week Range2.21 – 9.33
Volume54.5K
Avg Volume88.3K
Share Statistics
Shares Outstanding
Employees24
ExchangeXASE
Listed2023-08-09
Share count as of August 6, 2026
Loading Income Statement…
Key questions about Neuraxis, Inc. (NRXS)
What is Neuraxis, Inc.'s Market Cap?
Neuraxis, Inc.'s Market Cap is $73.8M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Enterprise Value?
Neuraxis, Inc.'s Enterprise Value is $65.5M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Price / Sales?
Neuraxis, Inc.'s Price / Sales is 13.9×, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s EV / Revenue?
Neuraxis, Inc.'s EV / Revenue is 12.3×, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s EV / EBITDA?
Neuraxis, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Revenue (TTM)?
Neuraxis, Inc.'s Revenue (TTM) is $5.3M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Net Income (TTM)?
Neuraxis, Inc.'s Net Income (TTM) is -$8.5M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s EBITDA?
Neuraxis, Inc.'s EBITDA is -$7.6M, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s Diluted EPS (TTM)?
Neuraxis, Inc.'s Diluted EPS (TTM) is -0.67, based on as-reported figures from SEC (XBRL) filings.
What is Neuraxis, Inc.'s EBITDA Margin?
Neuraxis, Inc.'s EBITDA Margin is -143.1%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+115.7%+79.5%+27.2%+21.7%
Cost of Revenue
Gross Profit
% of revenue85.9%86.4%85.4%83.3%
Selling, General and Administrative Expense
Research & Development
Operating Loss
% of revenue-110.2%-108.3%-177.3%-258.8%
Other Income (Expense):
Interest expense
Change in fair value of warrant liability
Non-Operating Income (Expense)
Total other income, net
Loss Before Income Taxes———
% of revenue-108.1%———
Net Loss
% of revenue-108.1%-109.5%-176.5%-261.6%
Preferred stock dividends
Net Loss Available to Common Stockholders
Earnings Per Share (Basic)
Earnings Per Share (Diluted)